Richard L. Friedman is the Deputy Director, Science and Regulatory Policy, Office of Manufacturing and Product Quality, which is part of the compliance office in FDA's Center for Drug Evaluation and Research (CDER). In this position, he is responsible for oversight of case review relating to drug manufacturing quality to assure scientific and risk-based decisions. This position includes review of regulatory action recommendations regarding inspections and manufacturing site acceptability, and promoting sound regulatory policy development. Mr. Friedman joined FDA in 1990 and his positions have included New Jersey District Drug Specialist, CDER Senior Compliance Officer, Team Leader of Guidance & Policy, Associate Director, and Division Director. Mr. Friedman has authored several publications on topics including sterile drugs and quality systems, and was awarded The George M. Sykes Award by the Parenteral Society for outstanding journal paper for the year 2005. He also received the 2011 Kenneth Chapman Achievement Award from the Institute of Validation Technology, and the 2012 Gordon Perseneus Award from PDA for scientific contributions in the area of drug quality. Mr. Friedman has been an adjunct faculty member of Temple University School of Pharmacy in their QA/RA graduate program since 2003. Prior to joining FDA, Mr. Friedman worked in the toxicology research division of Parke-Davis. Mr. Friedman received his B.S. in Biology with honors from Montclair State University in 1989, and his M.S. in Microbiology from Georgetown University School of Medicine in May, 2001.